Rocket Pharmaceuticals Inc — Financial Statements (NASDAQ:RCKT) | MetaTrader

Open full chart

Notizie

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Alpha Technology Group (NASDAQ:ATGL), Fulcrum Therapeutics (NASDAQ:FULC)

RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy

Wells Fargo, Walmart Lead Tuesday’s Market Cap Stock Movers

Goldman Sachs, Avago tech lead market cap stock movers on Tuesday

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock - Rocket Pharmaceuticals (NASDAQ:RCKT)

La FDA accetta la domanda di terapia genica di Rocket Pharmaceuticals per malattia rara

FDA accepts Rocket Pharmaceuticals’ gene therapy BLA for rare disease

Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday - American Resources (NASDAQ:AREC), Albertsons Companies (NYSE:ACI)

Leerink Partners abbassa il target di prezzo delle azioni di Rocket Pharmaceuticals dopo il ritiro della BLA